Topical treatment with paromomycin for cutaneous leishmaniasis
Dan Ben‐Amitai, Yehuda L. Danon, Shai Ashkenazi, Garty Bz
Abstract
Dan Ben‐Amitai, Yehuda L. Danon, Shai Ashkenazi, Garty Bz
Abstract
Cutaneous leishmaniasis, especially on the face, continues to present a complex therapeutic problem because of the potential formation of ugly scars. We present a 6-year-old girl who recently immigrated to Israel from Ethiopia with extensive facial lesions of cutaneous leishmaniasis. Treatment with ketoconazole caused liver damage. Local application of an ointment containing paromomycin sulfate and methylbenzethonium chloride for 3 weeks resulted in complete recovery with minimal scarring.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cutaneous leishmaniasis, especially on the face, continues to present a complex therapeutic problem because of the potential formation of ugly scars. We present a 6-year-old girl who recently immigrated to Israel from Ethiopia with extensive facial lesions of cutaneous leishmaniasis. Treatment with ketoconazole caused liver damage. Local application of an ointment containing paromomycin sulfate and methylbenzethonium chloride for 3 weeks resulted in complete recovery with minimal scarring.
Key concepts: Paromomycin, Medicine, Cutaneous leishmaniasis, Leishmaniasis, Dermatology, Scars, Protozoal disease, Ketoconazole